Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 16;15(2):e085456.
doi: 10.1136/bmjopen-2024-085456.

Models of care and associated targeted implementation strategies for cancer survivorship support in Europe: a scoping review protocol

Gillian Prue  1 , Johanna Czamanski-Cohen  2 , Angelos P Kassianos  3 , Sophie Pilleron  4 , Aristea Ladas  5 , Aysun Akcakaya Can  6 , Cristina Roldán-Jiménez  7   8 , Csaba Laszlo Degi  9 , Gökçe Işcan  10 , Sevban Arslan  11 , Angela G E M de Boer  12 , Aleksandar Celebic  13   14 , Ascensión Doñate-Martínez  15 , Tamara Alhambra-Borrás  16 , Boce Mitrevski  17 , Chiara Marzorati  18   19 , Gabriella Pravettoni  18   19 , Roberto Grasso  18   19 , Evsen Nazik  20 , Ewa Pawlowska  21 , Iva Mucalo  22 , John Patrick Browne  23 , Katica Tripkovic  24 , Katarina Vojvodic  24 , Maria Karekla  25 , Maria Moschofidou  26   27 , Sule Biyik Bayram  28 , Tânia Brandão  29 , Volker Arndt  30 , Poonam Jaswal  31 , Remziye Semerci  32 , Gamze Bozkul  33 , Eda Sahin  34 , Ismail Toygar  35 , Maximos Frountzas  36 , Rui Miguel Martins  37 , Michael Jefford  38 , Danielle Keane  39 , Josephine Hegarty  31   40
Affiliations

Models of care and associated targeted implementation strategies for cancer survivorship support in Europe: a scoping review protocol

Gillian Prue et al. BMJ Open. .

Abstract

Introduction: Cancer and its treatments can lead to a wide range of side-effects that can persist long after treatments have ended. Across Europe, survivorship care is traditionally hospital-based specialist-led follow-up, leading to gaps in supportive care. Improved screening, diagnosis and treatment increase survival rates. With more individuals living with, through and beyond cancer, the predominance of the hospital-based specialist model is unsustainable, costly and resource-intensive. An understanding of what alternative Models of Care are available and the barriers and facilitators to their implementation is a first step towards enhancing supportive care across the cancer journey. The aim of this scoping review is to source and synthesise information from studies evaluating patient-oriented models of cancer survivorship supportive care for adults in Europe.

Methods and analysis: The scoping review will be reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses-Scoping Review Extension guidelines and will be guided by a six-stage methodological framework. A search strategy has been developed according to the Population, Concept and Context structure and will be applied to seven databases. A targeted search of grey literature will be completed. All identified records will be screened using predefined eligibility criteria by at least two researchers and undergo full-text review for inclusion. Data pertaining to the conceptualisation, evaluation and implementation of sourced Models of Care will be extracted.

Ethics and dissemination: As there is no primary data, ethical approval is not required. This review will be conducted as part of the EU COST Action CA21152-Implementation Network Europe for Cancer Survivorship Care. The protocol and subsequent scoping review will be published in a peer-reviewed journal. The Action involves representatives from most countries across Europe which will assist with the dissemination of the work to key stakeholders.

Keywords: Delivery of Health Care, Integrated; Health Services; Health policy; International health services; Patient-Centered Care; Review.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

See all similar articles

References

    1. Guzzinati S, Virdone S, De Angelis R, et al. Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020. BMC Cancer. 2018;18:169. doi: 10.1186/s12885-018-4053-y. - DOI - PMC - PubMed
    1. Berns A, Ringborg U, Celis JE, et al. Towards a cancer mission in Horizon Europe: recommendations. Mol Oncol. 2020;14:1589–615. doi: 10.1002/1878-0261.12763. - DOI - PMC - PubMed
    1. European Commission A cancer plan for Europe. 2020. https://health.ec.europa.eu/publications/europes-beating-cancer-plan_en Available.
    1. De Angelis R, Demuru E, Baili P, et al. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 2024;25:293–307. doi: 10.1016/S1470-2045(23)00646-0. - DOI - PubMed
    1. National Reserach Council From cancer patient to cancer survivor lost in transition: National Academies Press. 2005. https://nap.nationalacademies.org/catalog/11613/from-cancer-patient-to-c... Available.